Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA.
|
Science
|
2001
|
3.02
|
2
|
Experience in 1,000 liver transplants under cyclosporine-steroid therapy: a survival report.
|
Transplant Proc
|
1988
|
2.87
|
3
|
The mannose-sensitive hemagglutinin of Vibrio cholerae promotes adherence to zooplankton.
|
Appl Environ Microbiol
|
2001
|
2.23
|
4
|
Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system.
|
J Am Coll Surg
|
1999
|
2.22
|
5
|
Human immunodeficiency virus type 1 Nef-induced down-modulation of CD4 is due to rapid internalization and degradation of surface CD4.
|
J Virol
|
1994
|
2.17
|
6
|
Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation.
|
J Am Coll Surg
|
1998
|
1.99
|
7
|
HIV-1 Nef increases T cell activation in a stimulus-dependent manner.
|
Proc Natl Acad Sci U S A
|
1999
|
1.92
|
8
|
Analysis of donor criteria for the prediction of outcome in clinical liver transplantation.
|
Transplant Proc
|
1987
|
1.90
|
9
|
Hepatic artery in liver transplantation.
|
Transplant Proc
|
1987
|
1.73
|
10
|
Human immunodeficiency virus type 1 Nef associates with a member of the p21-activated kinase family.
|
J Virol
|
1996
|
1.69
|
11
|
Liver transplantation using donation after cardiac death donors: long-term follow-up from a single center.
|
Am J Transplant
|
2009
|
1.59
|
12
|
The requirements for viral entry differ from those for virally induced syncytium formation in NIH 3T3/DTras cells exposed to Moloney murine leukemia virus.
|
J Virol
|
1992
|
1.58
|
13
|
Should hepatomas be treated with hepatic resection or transplantation?
|
Cancer
|
1999
|
1.54
|
14
|
Posterior reversible encephalopathy syndrome after solid organ transplantation.
|
AJNR Am J Neuroradiol
|
2008
|
1.53
|
15
|
Orthotopic liver transplantation for alcoholic cirrhosis.
|
JAMA
|
1988
|
1.45
|
16
|
Hepatic resection and transplantation for peripheral cholangiocarcinoma.
|
J Am Coll Surg
|
1997
|
1.36
|
17
|
Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation.
|
Hepatology
|
1997
|
1.36
|
18
|
OKT3 in the reversal of acute hepatic allograft rejection.
|
Transplant Proc
|
1987
|
1.35
|
19
|
Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system.
|
J Am Coll Surg
|
2000
|
1.33
|
20
|
Analysis of surgical complications after 397 hepatic transplantations.
|
Surg Gynecol Obstet
|
1990
|
1.25
|
21
|
Surgical management of leiomyosarcoma of the inferior vena cava.
|
J Gastrointest Surg
|
2008
|
1.24
|
22
|
Experience with primary liver transplantation across ABO blood groups.
|
Transplant Proc
|
1987
|
1.23
|
23
|
ICRP Publication 115. Lung cancer risk from radon and progeny and statement on radon.
|
Ann ICRP
|
2010
|
1.21
|
24
|
Adult to adult living-related liver transplant: report on an initial experience in Italy.
|
Dig Liver Dis
|
2007
|
1.16
|
25
|
A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients.
|
Transplantation
|
1999
|
1.14
|
26
|
Transplantation for primary biliary cirrhosis.
|
Gastroenterology
|
1988
|
1.12
|
27
|
Liver transplantation in the treatment of bleeding esophageal varices.
|
Surgery
|
1988
|
1.11
|
28
|
Development of colon cancer after liver transplantation for primary sclerosing cholangitis associated with ulcerative colitis.
|
Hepatology
|
1990
|
1.05
|
29
|
FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial.
|
Transplantation
|
1995
|
1.05
|
30
|
The Vibrio cholerae mannose-sensitive hemagglutinin is the receptor for a filamentous bacteriophage from V. cholerae O139.
|
Infect Immun
|
1998
|
1.02
|
31
|
Pretransplantation surveillance for possible hepatocellular carcinoma in patients with cirrhosis: epidemiology and CT-based tumor detection rate in 430 cases with surgical pathologic correlation.
|
Radiology
|
2000
|
1.01
|
32
|
HIV-1 Nef inhibits a common activation pathway in NIH-3T3 cells.
|
J Biol Chem
|
1994
|
1.01
|
33
|
IMBA Expert: internal dosimetry made simple.
|
Radiat Prot Dosimetry
|
2003
|
1.01
|
34
|
Reversal of hypersplenism following orthotopic liver transplantation.
|
Ann Surg
|
1989
|
0.99
|
35
|
Liver transplantation for fulminant hepatic failure.
|
Transplant Proc
|
1989
|
0.98
|
36
|
Modelling particle retention in the alveolar-interstitial region of the human lungs.
|
J Radiol Prot
|
2010
|
0.98
|
37
|
Mycotic pseudoaneurysm of the gastroduodenal artery--an unusual cause of lower gastrointestinal tract hemorrhage following liver transplantation.
|
Transplantation
|
1988
|
0.97
|
38
|
Effective dose from inhaled radon and its progeny.
|
Ann ICRP
|
2012
|
0.96
|
39
|
Cryptococcosis in liver and kidney transplant recipients receiving anti-thymocyte globulin or alemtuzumab.
|
Transpl Infect Dis
|
2007
|
0.95
|
40
|
Quantitative micro P30 and reverse transcriptase assays for Moloney murine leukemia virus.
|
J Virol Methods
|
1994
|
0.95
|
41
|
Is multiple organ failure a contraindication for liver transplantation in children?
|
Transplant Proc
|
1987
|
0.95
|
42
|
Late mortality and morbidity after liver transplantation.
|
Transplant Proc
|
1987
|
0.95
|
43
|
HIV Nef-mediated cellular phenotypes are differentially expressed as a function of intracellular Nef concentrations.
|
J Biol Chem
|
2001
|
0.94
|
44
|
Laparoscopic major hepatectomy: pure laparoscopic approach versus hand-assisted technique.
|
J Hepatobiliary Pancreat Sci
|
2013
|
0.92
|
45
|
Obstructing mucocele of the cystic duct after transplantation of the liver.
|
Surg Gynecol Obstet
|
1989
|
0.92
|
46
|
Mortality from internal and external radiation exposure in a cohort of male German uranium millers, 1946-2008.
|
Int Arch Occup Environ Health
|
2014
|
0.92
|
47
|
Cultured hepatoma cells as a model system for studying insulin processing and biologic responsiveness.
|
Diabetes
|
1980
|
0.92
|
48
|
Fulminant hepatic failure after repeated exposure to isoflurane anesthesia: a case report.
|
Hepatology
|
1991
|
0.92
|
49
|
HIV-1 Nef activity in murine T cells. CD4 modulation and positive enhancement.
|
J Immunol
|
1994
|
0.91
|
50
|
Pseudomonas aeruginosa bacteremia in patients undergoing liver transplantation: an emerging problem.
|
Surgery
|
1991
|
0.91
|
51
|
Surgical experience with hepatic colorectal metastasis.
|
Am Surg
|
1999
|
0.90
|
52
|
Hepatocellular carcinomas in native livers from patients treated with orthotopic liver transplantation: biologic and therapeutic implications.
|
Hepatology
|
2001
|
0.90
|
53
|
Assessment of intakes and doses to workers followed for 15 years after accidental inhalation of 60CO.
|
Health Phys
|
2007
|
0.90
|
54
|
Recurrent hepatocellular carcinoma after liver transplantation: spectrum of CT findings and recurrence patterns.
|
Radiology
|
1996
|
0.89
|
55
|
Safety of liver resection in the elderly: how important is age?
|
Ann Surg Oncol
|
2010
|
0.88
|
56
|
Accidental transplantation of malignant tumor from a donor to multiple recipients.
|
Transplantation
|
1987
|
0.87
|
57
|
Extended-spectrum beta-lactamase-producing Klebsiella spp. in a neonatal intensive care unit: risk factors for the infection and the dynamics of the molecular epidemiology.
|
Eur J Clin Microbiol Infect Dis
|
2007
|
0.86
|
58
|
Glycosylation of Escherichia coli L-asparaginase.
|
J Biol Chem
|
1977
|
0.86
|
59
|
Change in hepatic function, hemodynamics, and morphology after liver transplant. Physiological effect of therapy.
|
Ann Surg
|
1989
|
0.85
|
60
|
Prognostic models in hepatocellular carcinoma (HCC) and statistical methodologies behind them.
|
Curr Pharm Des
|
2007
|
0.84
|
61
|
Progress in liver transplantation.
|
Adv Surg
|
1988
|
0.83
|
62
|
Liver preservation with machine perfusion and a newly developed cell-free oxygen carrier solution under subnormothermic conditions.
|
Am J Transplant
|
2015
|
0.83
|
63
|
Analysis of T cell responses in liver allograft recipients. Evidence for deletion of donor-specific cytotoxic T cells in the peripheral circulation.
|
J Clin Invest
|
1993
|
0.83
|
64
|
Intrahepatic bile duct strictures after human orthotopic liver transplantation. Recurrence of primary sclerosing cholangitis or unusual presentation of allograft rejection?
|
Transpl Int
|
1988
|
0.83
|
65
|
Particle clearance in the alveolar-interstitial region of the human lungs: model validation.
|
Radiat Prot Dosimetry
|
2010
|
0.82
|
66
|
A safe immunosuppressive protocol in adult-to-adult living related liver transplantation.
|
Transplant Proc
|
2006
|
0.82
|
67
|
Screening for cerebral aneurysm in patients with polycystic liver disease.
|
South Med J
|
1999
|
0.81
|
68
|
Survival after liver transplantation in patients with hepatocellular carcinoma.
|
Princess Takamatsu Symp
|
1995
|
0.81
|
69
|
Successful retransplantation after a 48-hour anhepatic state.
|
Transplant Proc
|
1993
|
0.81
|
70
|
Systemic gadolinium toxicity in patients with renal insufficiency and renal failure: retrospective analysis of an initial experience.
|
Mayo Clin Proc
|
1996
|
0.81
|
71
|
Experimental determination of the absorption rate of unattached radon progeny from respiratory tract to blood.
|
Radiat Prot Dosimetry
|
2002
|
0.81
|
72
|
Hepatobiliary malignancies. Primary hepatic malignant neoplasms.
|
Surg Clin North Am
|
1999
|
0.80
|
73
|
Experience with Orthoclone OKT3 monoclonal antibody in liver transplantation.
|
Am J Kidney Dis
|
1988
|
0.80
|
74
|
Surgical technique of orthotopic liver transplantation.
|
Gastroenterol Clin North Am
|
1988
|
0.79
|
75
|
Undetected hepatocellular carcinoma: clinical features and outcome after liver transplantation.
|
Liver Transpl Surg
|
1998
|
0.79
|
76
|
Insulin-receptor interactions. Presence of a positive cooperative effect.
|
J Biol Chem
|
1984
|
0.78
|
77
|
Infections in pediatric liver recipients treated for acute rejection.
|
Transplant Proc
|
1989
|
0.78
|
78
|
Liver transplantation for chronic cholestatic liver disease in adults and children.
|
Gastroenterol Clin North Am
|
1988
|
0.78
|
79
|
Occupational dust and radiation exposure and mortality from stomach cancer among German uranium miners, 1946-2003.
|
Occup Environ Med
|
2011
|
0.78
|
80
|
Kinetic comparison of ricin immunotoxins: biricin conjugate has potentiated cytotoxicity.
|
Biochemistry
|
1986
|
0.78
|
81
|
Influence of endogenous Thy1.1 cells upon the efficacy of an anti-Thy1.1 antibody-diphtheria toxin conjugate.
|
Bioconjug Chem
|
1992
|
0.78
|
82
|
QT prolongation and Torsades de Pointes after administration of FK506.
|
Transplantation
|
1992
|
0.78
|
83
|
Presurgical evaluation of the liver transplant candidate.
|
Radiol Clin North Am
|
1995
|
0.77
|
84
|
Neurotoxicity of FK 506 in liver transplant recipients.
|
Transplant Proc
|
1993
|
0.77
|
85
|
Predicting the risk of tumor recurrence following transplantation for hepatocellular carcinoma.
|
Hepatology
|
1997
|
0.77
|
86
|
FK 506 rescue therapy: the rapidity of rejection reversal is related to the subsequent development of CMV disease.
|
Transplant Proc
|
1993
|
0.77
|
87
|
FK 506: reversal of humorally mediated rejection following ABO-incompatible liver transplantation.
|
Transplant Proc
|
1991
|
0.77
|
88
|
Biliary tract complications in orthotopic adult liver transplantation.
|
Am J Surg
|
1989
|
0.77
|
89
|
Results of an internal dose assessment intercomparison exercise after a EURADOS/IAEA training course.
|
Radiat Prot Dosimetry
|
2010
|
0.76
|
90
|
Characterization of antiidiotypic antibodies to donor HLA that develop after liver transplantation.
|
Transplantation
|
1993
|
0.76
|
91
|
Thrombolysis and endovascular stent placement for inferior vena caval thrombosis in a liver transplant recipient.
|
Transplantation
|
1997
|
0.76
|
92
|
Hepatic artery reconstruction for hepatic artery thrombosis after orthotopic liver transplantation.
|
Arch Surg
|
1990
|
0.76
|
93
|
Preservation of the retrohepatic vena cava during recipient hepatectomy for orthotopic transplantation of the liver.
|
Surg Gynecol Obstet
|
1989
|
0.75
|
94
|
WHICH LIVER-DESEASE PATIENTS NEED A TRANSPLANT?: Organ replacement has come into its own as a treatment for end-stage liver disease. A team of experts from two leading transplant centers reviews current indications, survival rates, and methods of evaluating candidates for operation.
|
Hosp Rec Study
|
1988
|
0.75
|
95
|
IMBA Professional Plus: a flexible approach to internal dosimetry.
|
Radiat Prot Dosimetry
|
2006
|
0.75
|
96
|
ERIDAS, a computer program for rapid calculation of internal doses from measurements of people in an emergency.
|
Radiat Prot Dosimetry
|
2007
|
0.75
|
97
|
The autocorrelation coefficient as a tool for assessing goodness of fit between bioassay predictions and measurement data.
|
Radiat Prot Dosimetry
|
2007
|
0.75
|
98
|
Internal dosimetry: towards harmonisation and coordination of research.
|
Radiat Prot Dosimetry
|
2008
|
0.75
|
99
|
Liver transplantation today.
|
Postgrad Med
|
1987
|
0.75
|
100
|
FK 506 rescue therapy: early conversion improves efficacy.
|
Transplant Proc
|
1993
|
0.75
|
101
|
EURADOS coordinated action on research, quality assurance and training of internal dose assessments.
|
Radiat Prot Dosimetry
|
2010
|
0.75
|
102
|
Methods for quantifying immunotoxin efficacy.
|
Cancer Treat Res
|
1988
|
0.75
|
103
|
Embolized portal vein catheter fragment in a liver transplant recipient: intraoperative removal using a snare.
|
J Vasc Interv Radiol
|
1995
|
0.75
|
104
|
A prospective randomized comparison of prophylactic ALG and OKT3 in cadaver kidney allograft recipients.
|
Transplant Proc
|
1991
|
0.75
|
105
|
FK 506 rescue therapy for hepatic allograft rejection: experience with an aggressive approach.
|
Clin Transplant
|
1995
|
0.75
|
106
|
Recurrent rejection following FK 506 rescue therapy for acute hepatic allograft rejection.
|
Transplant Proc
|
1993
|
0.75
|
107
|
Response to comments on 'Uncertainty analysis of the weighted equivalent lung dose per unit exposure to radon progeny in the home' by J. W. Marsh et al.
|
Radiat Prot Dosimetry
|
2003
|
0.75
|
108
|
Modified temporary end-to-side portocaval shunt in liver and small bowel transplantation.
|
Pediatr Transplant
|
2001
|
0.75
|
109
|
Note on the autocorrelation coefficient as a test statistic for assessment of the goodness-of-fit of biokinetic models to multiple bioassay data sets.
|
Radiat Prot Dosimetry
|
2013
|
0.75
|
110
|
Selective decontamination of the digestive tract in adult-to-adult living related liver transplant patients: a single centre experience.
|
Int J Antimicrob Agents
|
2008
|
0.75
|
111
|
Should reimbursement be denied for liver transplantation in patients with hepatocellular carcinoma?
|
JAMA
|
1997
|
0.75
|
112
|
Effect of dopamine infusion (3-30 microg/kg/min) on hepatic hemodynamics.
|
J Surg Res
|
2000
|
0.75
|
113
|
Obtaining an unbiased estimate of intake in routine monitoring when the time of intake is unknown.
|
Radiat Prot Dosimetry
|
2006
|
0.75
|
114
|
A prospective, randomized trial of tacrolimus/prednisone vs tacrolimus/prednisone/mycophenolate mofetil in renal transplantation: 1-year actuarial follow-up.
|
Transplant Proc
|
1999
|
0.75
|
115
|
In vivo measurement of unattached radon progeny deposited in the human respiratory tract.
|
Radiat Prot Dosimetry
|
2001
|
0.75
|
116
|
UK laboratory intercomparison on internal dosimetry.
|
Radiat Prot Dosimetry
|
2003
|
0.75
|
117
|
Avoiding biased estimates of dose when nothing is known about the time of intake.
|
Radiat Prot Dosimetry
|
2007
|
0.75
|
118
|
Mechanisms of xenobiotic activation in marine invertebrates.
|
Biochem Soc Trans
|
1991
|
0.75
|
119
|
Antibody-toxin conjugation.
|
Cancer Treat Res
|
1988
|
0.75
|
120
|
Bio-techniques for the detection of genetic toxicity in the aquatic environment.
|
J Biotechnol
|
1991
|
0.75
|
121
|
Reductive methylation of insulin. Production of a biologically active tritiated insulin.
|
Int J Pept Protein Res
|
1983
|
0.75
|
122
|
Technical aspects of living-related liver donation: single-center experience.
|
Transplant Proc
|
2009
|
0.75
|
123
|
Coordination of research on internal dosimetry in Europe: the CONRAD project.
|
Radiat Prot Dosimetry
|
2007
|
0.75
|